Onderneming Pear Therapeutics, Inc.
Aandelen
PEAR
US7047231052
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 200
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Maria Sullivan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yuri Maricich
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Ilya Gluhovsky
CTO | Chief Tech/Sci/R&D Officer | - | - |
Corey McCann
BRD | Director/Board Member | 45 | 01-12-21 |
Meara Murphy
IRC | Investor Relations Contact | - | - |
Beth Keyt
LAW | General Counsel | - | - |
Chris Valosky
SAM | Sales & Marketing | - | - |
Ellen Snow
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | 82 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 69 | 01-12-21 | |
Timothy Wicks
BRD | Director/Board Member | 58 | 14-06-22 |
Corey McCann
BRD | Director/Board Member | 45 | 01-12-21 |
Alison Bauerlein
BRD | Director/Board Member | 42 | 01-09-21 |
Shiva Rajaraman
BRD | Director/Board Member | 50 | 14-06-22 |
Paul Mango
BRD | Director/Board Member | - | 14-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 142 739 169 | 142 582 029 ( 99,89 %) | 0 | 99,89 % |
Bedrijfsgegevens
Pear Therapeutics, Inc.
200 State Street 13th Floor
02109, Boston
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,13% | 52,73 mld. | |
+37,49% | 39 mld. | |
-9,23% | 38,52 mld. | |
+28,38% | 30,38 mld. | |
-12,26% | 26,39 mld. | |
+11,45% | 26,08 mld. | |
+45,56% | 14,15 mld. | |
+33,03% | 12,6 mld. | |
-5,38% | 11,51 mld. |